Ken Rice

Title: Ken Rice - Innovator in Mast Cell Mediated Conditions Treatment

Introduction

Ken Rice is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of mast cell mediated conditions. His innovative work has led to the development of effective compounds and methods that address various inflammatory conditions.

Latest Patents

Ken Rice holds a patent for "Compositions and methods for treating mast-cell mediated conditions." This invention describes compounds, methods, and compositions that are effective in treating mast cell mediated inflammatory conditions, such as conjunctivitis, asthma, and allergic rhinitis. The compounds include novel mono- and di-aminomethylbenzyl, aminobenzyl, guanidylbenzyl, and benzyl tryptase inhibitors. The compositions for treating these conditions encompass oral, inhalant, and topical preparations, as well as devices that incorporate such preparations. He has 1 patent to his name.

Career Highlights

Ken Rice is associated with Arris Pharmaceutical Corporation, where he has been instrumental in advancing research and development in his area of expertise. His work has contributed to the understanding and treatment of conditions that significantly impact patients' quality of life.

Collaborations

Ken has collaborated with esteemed colleagues, including Barr E Bauer and Robert T Lum, to further enhance the research and development efforts at Arris Pharmaceutical Corporation.

Conclusion

Ken Rice's innovative contributions to the treatment of mast cell mediated conditions highlight his dedication to improving healthcare outcomes. His work continues to pave the way for advancements in pharmaceutical treatments.